hydroxychloroquine has been researched along with Chickungunya Fever in 7 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Post-chikungunya joint pain (arthritis or arthralgia) is a clinical concern in endemic regions as it may cause a debilitating illness sometimes years after the acute infection." | 2.82 | Treatment of chikungunya-associated joint pain: a systematic review of controlled clinical trials. ( Fernando, D; Herath, T; Rajapakse, S; Rodrigo, C; Wickramarachchi, U, 2022) |
| "The rapid spread of the new Coronavirus Disease 2019 (COVID-19) has actually become the newest challenge for the healthcare system since, to date, there is not an effective treatment." | 2.66 | Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and Chronic Diseases: A Systematic Review. ( De Tommasi, N; Faraone, I; Labanca, F; Milella, L; Ponticelli, M, 2020) |
| "Treatment with Sulfasalazine with and without methotrexate produced good response in 71." | 1.37 | Post-chikungunya chronic arthritis--our experience with DMARDs over two year follow up. ( Ganu, AS; Ganu, MA, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Rodrigo, C | 1 |
| Herath, T | 1 |
| Wickramarachchi, U | 1 |
| Fernando, D | 1 |
| Rajapakse, S | 1 |
| Nogueira, IA | 1 |
| Cordeiro, RA | 1 |
| Henn, GAL | 1 |
| Oliveira, JL | 1 |
| Faraone, I | 1 |
| Labanca, F | 1 |
| Ponticelli, M | 1 |
| De Tommasi, N | 1 |
| Milella, L | 1 |
| Cui, X | 1 |
| Sun, J | 1 |
| Minkove, SJ | 1 |
| Li, Y | 1 |
| Cooper, D | 1 |
| Couse, Z | 1 |
| Eichacker, PQ | 1 |
| Torabi-Parizi, P | 1 |
| MartÃ-Carvajal, A | 1 |
| Ramon-Pardo, P | 1 |
| Javelle, E | 1 |
| Simon, F | 1 |
| Aldighieri, S | 1 |
| Horvath, H | 1 |
| Rodriguez-Abreu, J | 1 |
| Reveiz, L | 1 |
| Ravindran, V | 1 |
| Alias, G | 1 |
| Ganu, MA | 1 |
| Ganu, AS | 1 |
4 reviews available for hydroxychloroquine and Chickungunya Fever
| Article | Year |
|---|---|
Treatment of chikungunya-associated joint pain: a systematic review of controlled clinical trials.
Topics: Anti-Inflammatory Agents; Arthralgia; Chikungunya Fever; Chloroquine; Humans; Hydroxychloroquine; Me | 2022 |
Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and Chronic Diseases: A Systematic Review.
Topics: Arthritis, Rheumatoid; Betacoronavirus; Chikungunya Fever; Chikungunya virus; Coronavirus Infections | 2020 |
Effects of chloroquine or hydroxychloroquine treatment on non-SARS-CoV2 viral infections: A systematic review of clinical studies.
Topics: Alphapapillomavirus; Antiviral Agents; Chikungunya Fever; Chikungunya virus; Chloroquine; COVID-19; | 2021 |
Interventions for treating patients with chikungunya virus infection-related rheumatic and musculoskeletal disorders: A systematic review.
Topics: Antirheumatic Agents; Chikungunya Fever; Chikungunya virus; Chloroquine; Humans; Hydroxychloroquine; | 2017 |
1 trial available for hydroxychloroquine and Chickungunya Fever
| Article | Year |
|---|---|
Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study.
Topics: Antirheumatic Agents; Arthritis, Infectious; Chikungunya Fever; Chronic Disease; Female; Humans; Hyd | 2017 |
2 other studies available for hydroxychloroquine and Chickungunya Fever
| Article | Year |
|---|---|
Hydroxychloroquine for the management of chronic chikungunya arthritis.
Topics: Arthritis; Chikungunya Fever; Chikungunya virus; Humans; Hydroxychloroquine | 2023 |
Post-chikungunya chronic arthritis--our experience with DMARDs over two year follow up.
Topics: Adult; Aged; Alphavirus Infections; Antirheumatic Agents; Arthritis, Rheumatoid; Chikungunya Fever; | 2011 |